Abilita Therapeutics is a biotechnology company focused on redefining the druggable landscape for multi-span membrane proteins, including G Protein Coupled Receptors (GPCRs), transporters and ion channels. We are building a rich pipeline of high-value assets for such targets, with the goal of becoming the leader in discovering and developing first- and best-in-class antibody therapeutics.
External link for Abilita Therapeutics, Inc.
3210 Merryfield Row
San Diego, CA 92121, US
Abilita Therapeutics, Inc. reposted this
Despite the development of powerful computational tools and wet-lab technologies, finding robust hits continues to be a major challenge for #drugdiscovery teams. We chat with Abilita Therapeutics, Inc. to discuss how they are addressing this challenge with new, innovative search tools.
Abilita Therapeutics will be attending Bio International in San Diego June 3-6. Click below to send us a meeting request in the BIO partnering system! #BIO2024 https://lnkd.in/g6ZfvzAR
Our CEO Mauro Mileni and VP of Research Chris Roth were recently featured in CAS to discuss their experience and perspective on pursuit of challenging membrane protein therapeutics. Abilita Therapeutics, based in San Diego, is a pioneering biotechnology company that enables the development of groundbreaking therapeutics for diseases lacking viable treatment options. Our innovative approach unlocks novel drug targets previously inaccessible, allowing us to address diseases with unmet medical needs and revolutionize patient care. #GPCRs #Ionchannels #transporters #biologics Two Bear Capital https://lnkd.in/gWecUMaG